Dr. Anna Malkina, MD

Dr. Malkina practices at Burlingame Surgical Center Inc in Burlingame, California.

Dr. Malkina's NPI, 1851626949, was assigned on October 8, 2009. Dr. Malkina graduated from UC San Diego School of Medicine in 2009. Dr. Malkina holds California license A116032.

Dr. Malkina's primary practice is Burlingame Surgical Center Inc, at 1750 El Camino Real, Burlingame, CA 94010 in San Mateo County. The practice phone is (650) 259-1480.

Dr. Malkina's primary practice is Burlingame Surgical Center Inc in Burlingame, California. Dr. Malkina is also affiliated with UCSF Helen Diller Medical Center at Parnassus Heights. The medical group on file is UCSF Medical Group. Dmand AI also links Dr. Malkina to 1 more hospital, 3 medical groups, 2 dialysis centers and 2 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Malkina practices, 6 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Malkina's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Malkina is board certified in internal medicine by the American Board of Internal Medicine. Dr. Malkina is licensed in California.

Dmand AI lists acute kidney failure, chronic kidney disease and fluid and electrolyte imbalances among the conditions Dr. Malkina treats.

CMS data shows 1,091 Medicare services from Dr. Malkina across 11 procedure codes in 2024, for 254 Medicare patients. Medicare paid $81,473 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 254 Medicare patients who saw Dr. Malkina in 2024. The largest group is 75 to 84, with 90 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 49% are also on Medicaid. Their average risk score is 3.36, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Malkina's median patient age at 75, with 49% women.

In 2024, Dr. Malkina wrote 858 Medicare Part D claims for 132 patients. 88% of them were for generic drugs. CMS names the drug for 731 of them, across 20 drugs with 11 or more claims each, at $105,170 in total drug cost. In 2023, CMS named 534 claims across 19 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Malkina for performance year 2024, reported as part of a group. Dr. Malkina accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Malkina as offering telehealth.

Dmand AI links 9 papers to Dr. Malkina, published from 2013 to 2025. 2018 was the busiest year, with 2. The most frequent topics are Renal Insufficiency, Chronic, Pilot Projects and Primary Health Care. Dr. Malkina's most frequent co-authors are Leah S. Karliner, MD, Michael Anders Kohn, MD and Michael George Shlipak, MD.

CMS Open Payments shows 24 general payments to Dr. Malkina from 6 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 92% of the total. Merck Sharp & Dohme Corporation paid the most, $8,750.

Dr. Malkina graduated from UC San Diego School of Medicine in 2009.

Dr. Malkina is in network with 8 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.